Why choose The Royal Marsden for MyTrack™ Myeloma?

We have designed MyTrack™ Myeloma here at Marsden using the newest evidence that's out there, including our own research and that of many other international myeloma experts, to come to a solution that allows people inside, but also outside, the Marsden to refer patients in by just means of sending bone marrow and blood material, and, in return, receiving an expert-designed integrated report that gives a clear vision on whether a patient is a potential candidate for a planned treatment break or not. We think that the precision and the innovation that we have put into this set of diagnostic tools, and the interpretation of the joint results, will really provide clinicians that look after myeloma patients with a new level of information that they can communicate easily with their patients, and can utilise likewise easily in their shared care plans that they design over time, as they follow patients along their often decade-long pathway. As a global leader in precision diagnostics, we at The Royal Marsden hospital are proud to offer this groundbreaking pathway that will hopefully improve the quality of life and the outcome for many myeloma patients.